Last Close
May 18  •  04:00PM ET
10.95
Dollar change
-0.65
Percentage change
-5.60
%
Category
Equity - Leveraged / Inverse
Asset Type
Equities (Stocks)
Tags
Return% 1Y
148.63%
Total Holdings
65
Perf Week
-13.16%
Sponsor
Direxion Shares
ETF Type
Tags
Return% 3Y
9.43%
AUM
12.73M
Perf Month
-18.53%
Fund Family
Bond Type
Tags
Return% 5Y
-8.76%
NAV/sh
Perf Quarter
-14.85%
Index
S&P Pharmaceuticals Sel Industry Indx
Average Maturity
Tags
Return% 10Y
52W High
14.25 -23.16%
Perf Half Y
20.59%
Index Weighting
Commodity Type
Tags
Return% SI
52W Low
4.74 131.01%
Perf YTD
-10.98%
Active/Passive
Quant Type
Tags
-
Flows% 1M
5.60%
Volatility
7.34% 6.03%
Perf Year
106.60%
ESG Type
Tags
-
Flows% 3M
-26.18%
ATR (14)
0.82
Perf 3Y
35.52%
Dividend Type
Sector/Theme
Flows% YTD
-23.58%
RSI (14)
39.09
Perf 5Y
-47.53%
Structure Type
Region
Flows% 1Y
Beta
1.82
Perf 10Y
-
Expense
0.98%
Growth/Value
SMA20
-13.02%
Flows% 3Y
Rel Volume
0.81
Prev Close
11.60
Inverse/Leveraged
Market Cap
SMA50
-4.86%
Flows% 5Y
Avg Volume
86.61K
Price
10.95
IPO
Nov 15, 2017
Option/Short
Yes / Yes
SMA200
5.98%
Trades
Volume
69,979
Change
-5.60%
Jan-16-26 02:30AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
08:30AM Loading…
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Mar-23-22 07:49AM
Jun-22-20 01:00PM
Feb-10-20 09:39AM
Jan-20-20 11:55AM
Jan-16-20 10:28AM
12:51PM Loading…
Jan-10-20 12:51PM
Nov-04-19 08:00AM
Nov-01-19 10:10AM
Aug-28-19 11:08AM
Jul-14-19 11:00AM
Jun-04-19 11:37AM
May-31-19 06:18PM
May-23-19 01:27PM
Apr-09-19 02:14PM
Feb-25-19 11:56AM
Jan-10-19 04:39PM
Jul-30-18 11:39AM
Jul-27-18 01:54PM
01:38PM
Jul-12-18 03:51PM
10:05AM Loading…
Jun-04-18 10:05AM
Nov-29-17 05:03PM
02:06PM
Nov-22-17 08:00AM
Nov-15-17 02:07PM
09:00AM
Feb-28-17 05:22PM
Feb-27-17 12:23PM
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.